Lichtenberger L M, Romero J J, Kao Y C, Dial E J
Department of Physiology and Cell Biology, University of Texas Medical School, Houston.
Gastroenterology. 1990 Aug;99(2):311-26. doi: 10.1016/0016-5085(90)91011-t.
It has been shown that intragastric treatment of rats with a suspension of dipalmitoylphosphatidylcholine and tripalmitin at a 1:4 ratio (5 mg lipid/mL per rat) provided rats with highly efficaceous and consistent protection against a variety of ulcerogenic agents and conditions. The gastric protective activity of this mixture was of long duration (t 1/2 approximately 9 hours. In an attempt to understand the mechanism of protection, it was determined that the ulcerogen-induced reduction in gastric surface hydrophobicity was reversed in rats pretreated with the mixture. However, the lipid mixture did not affect the gastric emptying rate and maintained its cytoprotective activity in indomethacin-treated rats. These results indicate that the mixture's protective effect was not mediated by alterations in either gastrointestinal motility or the gastric accumulation of lipids or "cytoprotective" metabolites (prostaglandins). The mixture also appreciably reduced gastric lesion score in response to acid if one or both the lipids was substituted for a metabolically inert ether analogue, suggesting that lipid metabolism makes a negligible contribution to the protective response. Electron microscopic observation indicated that the predominent structure in the mixture is a microemulsion in which a dipalmitoylphosphatidylcholine monolayer encapsulates a tripalmitin core. Last, the improved gastric protective activity of the mixture in comparison to dipalmitoylphosphatidylcholine liposomes is discussed regarding marked differences in the physical structure of the two suspensions and the rate at which lipids in these states adsorb to a surface to enhance its hydrophobic properties.
已表明,用二棕榈酰磷脂酰胆碱和三棕榈酸甘油酯按1:4比例的悬浮液(每只大鼠5毫克脂质/毫升)对大鼠进行胃内治疗,能为大鼠提供针对多种致溃疡剂和病症的高效且一致的保护。这种混合物的胃保护活性持续时间长(半衰期约为9小时)。为了理解保护机制,确定在用该混合物预处理的大鼠中,溃疡原诱导的胃表面疏水性降低得到了逆转。然而,脂质混合物不影响胃排空率,并且在吲哚美辛处理的大鼠中保持其细胞保护活性。这些结果表明,该混合物的保护作用不是由胃肠动力改变、脂质或“细胞保护”代谢物(前列腺素)的胃内蓄积介导的。如果将其中一种或两种脂质替换为代谢惰性的醚类似物,该混合物对酸引起的胃损伤评分也有明显降低,这表明脂质代谢对保护反应的贡献可忽略不计。电子显微镜观察表明,混合物中的主要结构是一种微乳液,其中二棕榈酰磷脂酰胆碱单层包裹着三棕榈酸甘油酯核心。最后,就两种悬浮液的物理结构以及这些状态下的脂质吸附到表面以增强其疏水特性的速率的显著差异,讨论了该混合物与二棕榈酰磷脂酰胆碱脂质体相比改善的胃保护活性。